A phase 3 trial of fOLFOX (5-FU, leucovorin, oxaliplatin), cAPOX (capecitabine, oxaliplatin) and capecitabine in colorectal cancer, run by Ralf Hofheinz, now recruiting.
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer is a phase 3, randomised interventional study registered as NCT04495088 by Ralf Hofheinz, with a registry enrolment figure of 550 participants, started 2020-09-30 and due to reach its primary completion in 2030-08. Interventions recorded: mFOLFOX (neoadjuvant); XELOX (neoadjuvant); mFOLFOX (adjuvant); XELOX (adjuvant); Capecitabine (adjuvant); infusional 5-FU/FA "AIO" regimen (adjuvant); infusional 5-FU/FA "de Gramont" (adjuvant). Conditions listed: Rectal Cancer. Primary outcome: disease-free survival. Colorectal eligibility wording from the registry: "Male and female patients with histologically confirmed diagnosis of rectal adenocarcinoma localised 0 - 16 cm from the anocutaneous line as measured by rigid rectoscopy (i". Sites: Germany. No results are recorded here; the registry entry is the source.
Shares CAPOX (capecitabine, oxaliplatin), FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.